BioPharm International, September 2023

Nanoparticles offer the potential for a safer, more effective method of drug delivery to the patient.

Image analysis algorithms coupled with microscopy techniques can be used to characterize aggregates of therapeutic proteins.

Process and bioreactor performance are directly impacted by real-time monitoring capabilities.

Innovations in downstream processing accelerate development, enhance efficiency, and promote sustainability.

Adventitious agent testing is transitioning toward testing methods that use next-generation sequencing.

The pandemic and shifting focus to more complex therapeutics are driving growth in the outsourced formulation development services market.

There are many promising trials in the pipeline that may bring big news for major therapeutic areas.

Audits and inspections both assure that requirements have been fulfilled and whether documented proof is available, says Siegfried Schmitt, vice president, Technical at Parexel.

Pharma's ability to continually reinvent itself will be critical in growing future business operations.